Literature DB >> 10613007

Control and prevention of the genetic load of haemoglobinopathies in India.

R S Balgir1.   

Abstract

Haemoglobinopathies and thalassaemia are inherited disorders which affect a large number of individuals in India. With a population of 950 million and a birth rate of 28 per thousand, it has been estimated that there would be about 42 million carriers and about 12,000 infants born each year will be inheriting a major haemoglobin disorder in India. In view of this heavy genetic load, frequent blood transfusions, high cost of treatment and management, physical trauma, and psychological and mental harassment to the patients and their families, it has been realized that the preventive genetic approach is the most suitable for the Indian setting. After carrier detection, prenatal diagnosis and genetic counselling are important options for couples at high risk for haemoglobinopathies. A prerequisite for a successful prevention and control programme is health education, public awareness and sensitization, and screening of the population for identification of heterozygotes or carriers in the community.

Entities:  

Mesh:

Year:  1999        PMID: 10613007

Source DB:  PubMed          Journal:  Natl Med J India        ISSN: 0970-258X            Impact factor:   0.537


  3 in total

1.  Genetic diversity of hemoglobinopathies, G6PD deficiency, and ABO and Rhesus blood groups in two isolates of a primitive Kharia Tribe in Sundargarh District of Northwestern Orissa, India.

Authors:  R S Balgir
Journal:  J Community Genet       Date:  2010-09-01

2.  Prevalence of hemoglobinopathy, ABO and rhesus blood groups in rural areas of West Bengal, India.

Authors:  Bikash Mondal; Soumyajit Maiti; Biplab Kumar Biswas; Debidas Ghosh; Shyamapada Paul
Journal:  J Res Med Sci       Date:  2012-08       Impact factor: 1.852

3.  A monozygotic twin pair with β-thalassemia carrier status in a Dudh Kharia tribal family of Orissa.

Authors:  R S Balgir
Journal:  Indian J Hum Genet       Date:  2007-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.